Cognition Therapeutics, Inc. (CGTX) vs VAXART, INC. (VXRT)
Cognition Therapeutics, Inc. and VAXART, INC. are both Biotechnology companies. Cognition Therapeutics, Inc. and VAXART, INC. are of similar size ($92.4M and $90.7M). Cognition Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; VAXART, INC. trades at 2.8×. VAXART, INC. has the higher net margin (15.9% vs 0.00%) and the higher return on invested capital (134.6% vs 0.00%). Across the 13 metrics below, VAXART, INC. leads on 12 and Cognition Therapeutics, Inc. on 1.
Valuation
Profitability
| Metric | CGTX | VXRT | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 100.00% | 65.16% |
| Operating margin | 0.00% | 16.30% | 0.00% |
| Net margin | 0.00% | 15.88% | 0.00% |
| Free cash flow margin | 0.00% | 13.74% | 0.00% |
| Return on equity | (83.76%) | 66.97% | (57.72%) |
| Return on assets | (57.33%) | 23.44% | (49.22%) |
| Return on invested capital | 0.00% | 134.59% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack